TWD 86.9
(-12.4%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 24.24 Million TWD | -21.44% |
2022 | 30.86 Million TWD | 77.8% |
2021 | 17.35 Million TWD | 221.8% |
2020 | 5.39 Million TWD | 60.97% |
2019 | 3.35 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 31.59 Million TWD | 30.3% |
2024 Q2 | 31.59 Million TWD | 0.0% |
2023 Q4 | 24.24 Million TWD | 0.0% |
2023 FY | 24.24 Million TWD | -21.44% |
2023 Q3 | 24.24 Million TWD | -33.18% |
2023 Q1 | 36.28 Million TWD | 17.58% |
2023 Q2 | 36.28 Million TWD | 0.0% |
2022 Q3 | 30.86 Million TWD | 0.0% |
2022 FY | 30.86 Million TWD | 77.8% |
2022 Q4 | 30.86 Million TWD | 0.0% |
2021 FY | 17.35 Million TWD | 221.8% |
2020 FY | 5.39 Million TWD | 60.97% |
2019 FY | - TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
BIONET Corp. | 55.53 Million TWD | 56.342% |
DIVA Laboratories, Ltd. | 196.2 Million TWD | 87.642% |
Genetics Generation Advancement Corp. | 34.79 Million TWD | 30.321% |
Welgene Biotech Co.,Ltd. | 53.77 Million TWD | 54.906% |
TFBS Bioscience Inc. | 8.84 Million TWD | -174.194% |